These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15468560)

  • 1. [Neuroprotection by ketamine and dopamine-saving drugs in severe craniocerebral trauma at exacerbation and in the treatment of apallic syndrome].
    Vereshchagin EI; Tarasov RS; Astrakov SV; Lokotkova OV; Egorov AV; Volkov SG; Vereshchagin IP
    Anesteziol Reanimatol; 2004; (4):54-6. PubMed ID: 15468560
    [No Abstract]   [Full Text] [Related]  

  • 2. [The mechanism of neuroprotective action of clonidine].
    Karmen NB
    Anesteziol Reanimatol; 2005; (3):53-7. PubMed ID: 16076049
    [No Abstract]   [Full Text] [Related]  

  • 3. In Vogue: Ketamine for Neuroprotection in Acute Neurologic Injury.
    Bell JD
    Anesth Analg; 2017 Apr; 124(4):1237-1243. PubMed ID: 28079589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection: challenges and opportunities.
    Faden AI; Stoica B
    Arch Neurol; 2007 Jun; 64(6):794-800. PubMed ID: 17562927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective trials: no longer a cautious optimism.
    Friedman JH
    Med Health R I; 2008 Jun; 91(6):158. PubMed ID: 18610798
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental justification of the use of benzimidazole derivatives as antiasthenic agents after craniocerebral trauma].
    Zarubina IV; Nurmanbetova FN; Shabanov PD
    Eksp Klin Farmakol; 2005; 68(3):46-9. PubMed ID: 16047681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of amantadine sulfate (PK-MERZ) during emergence from coma: results of a multicenter study].
    Belkin AA; Shchegolev AV; Kondrat'ev AN; Bubnova ID
    Anesteziol Reanimatol; 2008; (2):70-3. PubMed ID: 18540467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A contribution to the problem of recovery from posttraumatic apallic syndrome].
    Lenart-Jankowska D; Wender M
    Neurol Neurochir Pol; 1997; 31(3):587-91. PubMed ID: 9446049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair.
    Saver JL
    Rev Neurol Dis; 2008; 5(4):167-77. PubMed ID: 19122569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurophysiological indices of the CNS plasticity in the course of treatment of craniocerebral trauma in adolescents].
    Iznak AF; Iznak EV; Zavadenko NN; Guzilova LS
    Fiziol Cheloveka; 2008; 34(6):23-9. PubMed ID: 19133534
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical appraisal of neuroprotection trials in head injury: what have we learned?
    Tolias CM; Bullock MR
    NeuroRx; 2004 Jan; 1(1):71-9. PubMed ID: 15717008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Observation on electroacupuncture combined with routine western medicine therapy for promoting consciousness of the patient with coma caused by craniocerebral trauma].
    Fu YY; Cao SQ; Zhuang JX; Hu L; Chen DK; Gu FJ
    Zhongguo Zhen Jiu; 2009 Feb; 29(2):107-10. PubMed ID: 19391532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatments in the early stage of Parkinson disease].
    Rascol O
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F77-84. PubMed ID: 18680822
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythropoietin improves oxidative stress following spinal cord trauma in rats.
    Yazihan N; Uzuner K; Salman B; Vural M; Koken T; Arslantas A
    Injury; 2008 Dec; 39(12):1408-13. PubMed ID: 18635178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties (Toxicol. Appl. Pharmacol. 232, 351-358, 2008).
    Dorandeu F; Carpentier P; Dhote F; Mion G; Baille V; Testylier G; Lallement G
    Toxicol Appl Pharmacol; 2009 Jul; 238(2):188; author reply 189. PubMed ID: 19445958
    [No Abstract]   [Full Text] [Related]  

  • 16. Cortical spread depolarization and ketamine: a revival of an old drug or a new era of neuroprotective drugs?
    Welling L; Welling MS; Teixeira MJ; Figueiredo EG
    World Neurosurg; 2015 Apr; 83(4):396-7. PubMed ID: 25644895
    [No Abstract]   [Full Text] [Related]  

  • 17. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
    Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
    Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
    [No Abstract]   [Full Text] [Related]  

  • 18. Contemporary treatment paradigms in head injury.
    Wilberger JE
    Clin Neurosurg; 2000; 46():143-52. PubMed ID: 10944673
    [No Abstract]   [Full Text] [Related]  

  • 19. A responsive outcome for Parkinson's disease neuroprotection futility studies.
    Elm JJ; Goetz CG; Ravina B; Shannon K; Wooten GF; Tanner CM; Palesch YY; Huang P; Guimaraes P; Kamp C; Tilley BC; Kieburtz K;
    Ann Neurol; 2005 Feb; 57(2):197-203. PubMed ID: 15668964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine for rapid sequence induction in patients with head injury in the emergency department.
    Sehdev RS; Symmons DA; Kindl K
    Emerg Med Australas; 2006 Feb; 18(1):37-44. PubMed ID: 16454773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.